From Science to Policy ─ Evolution of China’s Needle Exchange Program (NEP) Xiaobin Cao Ph.D National Center for AIDS/STD Control and Prevention China.

Slides:



Advertisements
Similar presentations
The HIV Situation in Cameroon and Kumbo Yosuke INOUE School of Health Sciences and Nursing Faculty of Medicine The University of Tokyo NAVTI Foundation.
Advertisements

Community Attitudes Toward Harm Reduction for Injection Drug Users (IDUs): Evidence from a Cross-Border HIV Prevention Project in Ning Ming County (Guangxi.
The Regional Classification & Its Challenges in the Chinese Regional Policy System Wang Qingyun Prof. PH.D ( The Academy of Macroeconomic Research, NDRC.
Kathleen H. Reilly, MPH 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention Rome, Italy July 18, 2011.
Learning and Empowerment: “Key Issues in Strategies for HIV/AIDS Prevention” March 1-5, 2004, Chiang Mai Presented by Dr. Pum Sophiny, Program Officer.
The History, Current Status, and Future Prospects of Barefoot Doctors in China China Rural Health Association Dr. Wang Shucheng.
CDC-NIMH Conference Closing Meditations Thomas J. Coates PhD Professor of Medicine Director, AIDS Research Institute University of California San Francisco.
Doing the Right Thing Karen A. Stanecki XV International AIDS Conference.
Injecting Drug Users: A Global Problem Roger Detels, M.D., M.S.
Add text here Jessica Zhang, China Business Advisor China-Britain Business Council Tuesday 15 July 2014 – Liverpool IFB China – Land of Opportunity The.
Organization of Computer Science Faculty in China Dianfu Ma Faculty of Computer Science Beihang University
HIV/AIDS in China Kong_Lai Zhang Professor, Department of Epidemiology, Peking Union Medical College.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
AIDS Epidemic and Control in China Zeng Yi Chinese Foundation for Prevention of STD and AIDS.
HIV and drug prevention in Estonia Harm reduction services
Marc Bulterys, MD PhD Director, Global AIDS Program, China U.S. Centers for Disease Control and Prevention International AIDS Conference (TUSA14) Washington,
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
Risk evaluation of schistosomiasis japonica input to the Chaohu Lake region in Anhui province of China Cao Zhi-guo Deputy director Dept. of Disease Surveillance.
Updates on the Chinese Energy Sector Yanjia Wang Tsinghua University, China 5th Asia Energy Security Workshop 31 st October 2007, Beijing.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Key Affected Populations.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
By S AATCHI & S AATCHI & TEAM ONE September 13, 2006 Establishing LDA in China.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Washington D.C., USA, July 2012www.aids2012.org Alternatives to NSEPs: community-based initiatives Providing access to syringes in the politically.
Integrating Sustainable HIV Prevention Information into Bangladesh’s National Education Curricula – A best practice case from the South Asia Region Presenter:
Feedback from Bangkok conference. The international “Harm reduction” strategy: According to world statistics more than 12 millions people are injection.
HIV Epidemic and Response among MSM in China Han Mengjie 23 July, 2014.
Plan © Plan HIV/AIDS. © Plan 2 Average life expectancy in 11 African Countries (age in years) Country/ 国家 Before AIDS/ 流行前 2010 Angola Botswana
The development of China’s trade and China’s trade surplus The development of China’s trade after the reform and opening up Since the reform and.
Situation of HIV Epidemic & Response in China CMT Retreat 3 February 2010.
Cases of H7N9 Influenza in China by Week of Onset (6/11/13)* *133 total cases/39 deaths; date of onset missing for 10 cases Cases Deceased Cases Alive.
1 Lambaa.S Member of parliament of Mongolia, Minister of Health National Conference on HIV/AIDS Hotel Chingis, Dec.2-3, 2008 Government role in prevention.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
China’s Energy Challenge: Adjusting to Higher Prices Tao Wang Head of Asia Economics, BP Oct 13, 2006, Moscow.
中国是什么 ? What is China?. Well….. It is….And it is also….
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
China’s regional distribution of wealth. GDP exercise Look at the figures showing the GDP per capita for different administrative regions in China Produce.
Audience Appreciation Survey of Phoenix TV H2, 2015 Source: CTR Market Research.
Application of Pinch Analysis Approach to CO 2 Emission Constrained Energy Planning: Dingjiang Chen 1, Jianfeng Cai 1, Bing Zhu 1,2 1 Dept. of Chem. Eng.,
BURUNDI PERMANENT EXECUTIVE SECRETARIAT (SEP) NATIONAL AIDS COUNCIL (C N L S) Epidemic situation and national response for prevention in Burundi PRESENTED.
NOUS SOIGNONS CEUX QUE LE MONDE OUBLIE PEU A PEU Starting needle exchange programming for injecting drug users (IDUs) in Temeke District, Dar-es- Salaam,
Regional Economic Growth
High HIV prevalence among drug injecting female sex workers in Viet Nam: The need to reduce both sexual and injection risks in this vulnerable population.
Cases Deceased Cases Alive Source: WHO, Flutrackers, news reports.
Zimbabwe’s shift towards treat all: national country context
Note: Total cases include an
Cases of H7N9 Influenza in China by Week of Onset (2/10/14)*
The analysis and advocacy (A2) project: Role in translating Thailand’s national AIDS strategy into provincial implementation plans S. Pantuwatana1, S.
Cases Deceased Cases Alive
Cases Deceased Cases Alive Source: WHO, Flutrackers, news reports.
Key Affected Populations
Administrative Divisions of the People’s Repubic
China 2010 UNGASS Country Progress Report
Cases Deceased Cases Alive
The HIV Epidemic among People who Inject Drugs
Key Affected Populations
Cases Deceased Cases Alive Source: WHO, Flutrackers, news reports.
Cases of H7N9 Influenza in China by Age-Group (1/27/14)*
Cases of H7N9 Influenza in China by Week of Onset (1/30/14)*
World-Class Disciplines Evaluation in Mainland China -Case Study of Chinese Postgraduate Education and Discipline Evaluation Prof. Junping Qiu, Dr.
Location of H7N9 Influenza in China (2/3/14)*
Gao Kao and Social Equality
Note: Total cases include an
Map illustrating the current and former areas of endemic schistosomiasis (shaded) in China. Map illustrating the current and former areas of endemic schistosomiasis.
Cases of H7N9 Influenza in China by Week of Onset (2/6/14)*
Dr Dan Wu SESH and Zhuhai team, China 24 July, 2019
Review in slides Most-at-risk populations
World-Class Disciplines Evaluation in Mainland China -Case Study of Chinese Postgraduate Education and Discipline Evaluation Prof. Junping Qiu, Dr.
Presentation transcript:

From Science to Policy ─ Evolution of China’s Needle Exchange Program (NEP) Xiaobin Cao Ph.D National Center for AIDS/STD Control and Prevention China CDC July 23, 2012 Washington DC

Contributors ɠ Dr. Wu Zunyou, China CDC ɠ China’s National NEP Working Group ɠ China Ministry of Health ɠ International community: Global Fund US, UK et al. ɠ AIDS 2012 Conference Secretariat

Why China Initiated NEPs? ɠ Large number of heroin users more than 1 million ɠ High HIV prevalence 6% nationwide ɠ Prevalent high-risk behavior among drug users: high needle sharing low condom use ɠ NEP has been proven to be an effective harm reduction strategy worldwide. 2 HIV sentinel surveillance data on IDUs,

4 Evidence-based Evolution ɠ A small pilot feasibility study in 1997, sponsored by World AIDS Foundation ɠ The first NEP Workshop in 1997, hosted by Chinese Preventive Medicine Academy. ɠ A scale-up pilot study in two provinces in 1999, sponsored by China Ministry of Health. ɠ Implementation in four provinces since 2000, sponsored by China-UK Program and China-Australia Program. ɠ Scale-up nationwide since 2003, sponsored by China CARE program.

Milestones in China’s NEP First NEP workshop in China (1997) China CARE project ( 2003) Scale up Pilot NEP study in 2 provinces ( 1999) 3 rd Five year Action Plan ( ) Preparation Phase ( Before 1999) Pilot Phase ( 1999 to 2003) National Scale-up Phase ( Since Jul, 2003) Web-based Data Management System (2008) 1 st Five-year AIDS Plan ( ) 2 nd Five-year AIDS Plan ( )

6 Supportive Legislations Former Minister of Health visited NEP sties Policy and Third Five-year AIDS Action Plan ( ), issued by State Council, the Central Government

Geographical Distribution XINJIANG QINGHAI YUNNAN GUANGXI GUANGDONG SICHUAN NINGXIA SHAANXI GUIZHOU HUNAN HUBEI JIANGXI BEIJING JIANGSU ZHEJIANG FUJIAN HAINAN CHONGQING By March 2012, 966 NEP sites 466 counties in 18 provinces, covering 44,530 injecting drug users monthly (50 drug users per site)

NEP in China ɠ Financial sources: Before 2010: Government & international support; After 2010: Government ɠ NEP operators: Peer educators, CDCs, NGOs, pharmacies ɠ Participants of NEP: Heroin users recruited from community 8 NEP Guideline

Web-based Data Management System 9

ɠ Misunderstanding of drug use and debate on NEP still exists. ɠ Lack of comprehensive evaluation on the role of NEP in HIV prevention in China. ɠ Which NEP model is better in China? Peer educators (how can we know they really distribute?) Health workers NGO? Challenges

ɠ Decrease the negative attitude toward drug use and NEPs. ɠ Strengthen the leadership on NEPs. ɠ Implement the comprehensive evaluation on NEPs. ɠ Encourage the active involvement of target population: e.g. Community-based organizations (CBOs), Grass-rooted organizations Next Steps

Thank you !